Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)

Gregg W. Stone; Akiko Maehara; James E. Muller; David G. Rizik; Kendrick A. Shunk; Ori Ben-Yehuda; Philippe Genereux; Ovidiu Dressler; Rupa Parvataneni; Sean Madden; Priti Shah; Emmanouil S. Brilakis; Annapoorna S. Kini

doi:10.1016/j.jcin.2015.01.032

Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)

Gregg W. Stone, Akiko Maehara, James E. Muller, David G. Rizik, Kendrick A. Shunk, Ori Ben-Yehuda, Philippe Genereux, Ovidiu Dressler, Rupa Parvataneni, Sean Madden, Priti Shah, Emmanouil S. Brilakis, Annapoorna S. Kini

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Abstract

Abstract Objectives This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies lipid-rich plaques at risk of periprocedural myonecrosis and whether these events may be prevented by the use of a distal protection filter during PCI. Background Lipid-rich plaques may be prone to distal embolization and periprocedural myocardial infarction (MI) in patients undergoing PCI. Methods Patients undergoing stent implantation of a single native coronary lesion were enrolled in a multicenter, prospective trial. Near-infrared spectroscopy and intravascular ultrasound were performed at baseline, and lesions with a maximal lipid core burden index over any 4-mm length (maxLCBI_4mm) ≥600 were randomized to PCI with versus without a distal protection filter. The primary endpoint was periprocedural MI, defined as troponin or a creatine kinase-myocardial band increase to 3 or more times the upper limit of normal. Results Eighty-five patients were enrolled at 9 U.S. sites. The median (interquartile range) maxLCBI_4mm was 448.4 (274.8 to 654.4) pre-PCI and decreased to 156.0 (75.6 to 312.6) post-PCI (p < 0.0001). Periprocedural MI developed in 21 patients (24.7%). The maxLCBI_4mm was higher in patients with versus without MI (481.5 [425.6 to 679.6] vs. 371.5 [228.9 to 611.6], p = 0.05). Among 31 randomized lesions with maxLCBI_4mm ≥600, there was no difference in the rates of periprocedural MI with versus without the use of a distal protection filter (35.7% vs. 23.5%, respectively; relative risk: 1.52; 95% confidence interval: 0.50 to 4.60, p = 0.69). Conclusions Plaque characterization by near-infrared spectroscopy identifies lipid-rich lesions with an increased likelihood of periprocedural MI after stent implantation, presumably due to distal embolization. However, in this pilot randomized trial, the use of a distal protection filter did not prevent myonecrosis after PCI of lipid-rich plaques.

Original language	English (US)
Article number	1997
Pages (from-to)	927-936
Number of pages	10
Journal	JACC: Cardiovascular Interventions
Volume	8
Issue number	7
DOIs	https://doi.org/10.1016/j.jcin.2015.01.032
State	Published - Jun 1 2015

Keywords

atherosclerosis
distal protection
embolization
myocardial infarction
near-infrared spectroscopy

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jcin.2015.01.032

Fingerprint

Dive into the research topics of 'Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)'. Together they form a unique fingerprint.

Cite this

Stone, G. W., Maehara, A., Muller, J. E., Rizik, D. G., Shunk, K. A., Ben-Yehuda, O., Genereux, P., Dressler, O., Parvataneni, R., Madden, S., Shah, P., Brilakis, E. S., & Kini, A. S. (2015). Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). JACC: Cardiovascular Interventions, 8(7), 927-936. Article 1997. https://doi.org/10.1016/j.jcin.2015.01.032

Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). / Stone, Gregg W.; Maehara, Akiko; Muller, James E. et al.
In: JACC: Cardiovascular Interventions, Vol. 8, No. 7, 1997, 01.06.2015, p. 927-936.

Research output: Contribution to journal › Article › peer-review

Stone, GW, Maehara, A, Muller, JE, Rizik, DG, Shunk, KA, Ben-Yehuda, O, Genereux, P, Dressler, O, Parvataneni, R, Madden, S, Shah, P, Brilakis, ES & Kini, AS 2015, 'Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)', JACC: Cardiovascular Interventions, vol. 8, no. 7, 1997, pp. 927-936. https://doi.org/10.1016/j.jcin.2015.01.032

Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O et al. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). JACC: Cardiovascular Interventions. 2015 Jun 1;8(7):927-936. 1997. doi: 10.1016/j.jcin.2015.01.032

Stone, Gregg W. ; Maehara, Akiko ; Muller, James E. et al. / Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention : The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). In: JACC: Cardiovascular Interventions. 2015 ; Vol. 8, No. 7. pp. 927-936.

@article{b60436b827154741819fff6b8b955342,

title = "Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)",

abstract = "Abstract Objectives This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies lipid-rich plaques at risk of periprocedural myonecrosis and whether these events may be prevented by the use of a distal protection filter during PCI. Background Lipid-rich plaques may be prone to distal embolization and periprocedural myocardial infarction (MI) in patients undergoing PCI. Methods Patients undergoing stent implantation of a single native coronary lesion were enrolled in a multicenter, prospective trial. Near-infrared spectroscopy and intravascular ultrasound were performed at baseline, and lesions with a maximal lipid core burden index over any 4-mm length (maxLCBI4mm) ≥600 were randomized to PCI with versus without a distal protection filter. The primary endpoint was periprocedural MI, defined as troponin or a creatine kinase-myocardial band increase to 3 or more times the upper limit of normal. Results Eighty-five patients were enrolled at 9 U.S. sites. The median (interquartile range) maxLCBI4mm was 448.4 (274.8 to 654.4) pre-PCI and decreased to 156.0 (75.6 to 312.6) post-PCI (p < 0.0001). Periprocedural MI developed in 21 patients (24.7%). The maxLCBI4mm was higher in patients with versus without MI (481.5 [425.6 to 679.6] vs. 371.5 [228.9 to 611.6], p = 0.05). Among 31 randomized lesions with maxLCBI4mm ≥600, there was no difference in the rates of periprocedural MI with versus without the use of a distal protection filter (35.7% vs. 23.5%, respectively; relative risk: 1.52; 95% confidence interval: 0.50 to 4.60, p = 0.69). Conclusions Plaque characterization by near-infrared spectroscopy identifies lipid-rich lesions with an increased likelihood of periprocedural MI after stent implantation, presumably due to distal embolization. However, in this pilot randomized trial, the use of a distal protection filter did not prevent myonecrosis after PCI of lipid-rich plaques.",

keywords = "atherosclerosis, distal protection, embolization, myocardial infarction, near-infrared spectroscopy",

author = "Stone, {Gregg W.} and Akiko Maehara and Muller, {James E.} and Rizik, {David G.} and Shunk, {Kendrick A.} and Ori Ben-Yehuda and Philippe Genereux and Ovidiu Dressler and Rupa Parvataneni and Sean Madden and Priti Shah and Brilakis, {Emmanouil S.} and Kini, {Annapoorna S.}",

note = "Publisher Copyright: {\textcopyright} 2015 American College of Cardiology Foundation.",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/j.jcin.2015.01.032",

language = "English (US)",

volume = "8",

pages = "927--936",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention

T2 - The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)

AU - Stone, Gregg W.

AU - Maehara, Akiko

AU - Muller, James E.

AU - Rizik, David G.

AU - Shunk, Kendrick A.

AU - Ben-Yehuda, Ori

AU - Genereux, Philippe

AU - Dressler, Ovidiu

AU - Parvataneni, Rupa

AU - Madden, Sean

AU - Shah, Priti

AU - Brilakis, Emmanouil S.

AU - Kini, Annapoorna S.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Abstract Objectives This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies lipid-rich plaques at risk of periprocedural myonecrosis and whether these events may be prevented by the use of a distal protection filter during PCI. Background Lipid-rich plaques may be prone to distal embolization and periprocedural myocardial infarction (MI) in patients undergoing PCI. Methods Patients undergoing stent implantation of a single native coronary lesion were enrolled in a multicenter, prospective trial. Near-infrared spectroscopy and intravascular ultrasound were performed at baseline, and lesions with a maximal lipid core burden index over any 4-mm length (maxLCBI4mm) ≥600 were randomized to PCI with versus without a distal protection filter. The primary endpoint was periprocedural MI, defined as troponin or a creatine kinase-myocardial band increase to 3 or more times the upper limit of normal. Results Eighty-five patients were enrolled at 9 U.S. sites. The median (interquartile range) maxLCBI4mm was 448.4 (274.8 to 654.4) pre-PCI and decreased to 156.0 (75.6 to 312.6) post-PCI (p < 0.0001). Periprocedural MI developed in 21 patients (24.7%). The maxLCBI4mm was higher in patients with versus without MI (481.5 [425.6 to 679.6] vs. 371.5 [228.9 to 611.6], p = 0.05). Among 31 randomized lesions with maxLCBI4mm ≥600, there was no difference in the rates of periprocedural MI with versus without the use of a distal protection filter (35.7% vs. 23.5%, respectively; relative risk: 1.52; 95% confidence interval: 0.50 to 4.60, p = 0.69). Conclusions Plaque characterization by near-infrared spectroscopy identifies lipid-rich lesions with an increased likelihood of periprocedural MI after stent implantation, presumably due to distal embolization. However, in this pilot randomized trial, the use of a distal protection filter did not prevent myonecrosis after PCI of lipid-rich plaques.

AB - Abstract Objectives This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies lipid-rich plaques at risk of periprocedural myonecrosis and whether these events may be prevented by the use of a distal protection filter during PCI. Background Lipid-rich plaques may be prone to distal embolization and periprocedural myocardial infarction (MI) in patients undergoing PCI. Methods Patients undergoing stent implantation of a single native coronary lesion were enrolled in a multicenter, prospective trial. Near-infrared spectroscopy and intravascular ultrasound were performed at baseline, and lesions with a maximal lipid core burden index over any 4-mm length (maxLCBI4mm) ≥600 were randomized to PCI with versus without a distal protection filter. The primary endpoint was periprocedural MI, defined as troponin or a creatine kinase-myocardial band increase to 3 or more times the upper limit of normal. Results Eighty-five patients were enrolled at 9 U.S. sites. The median (interquartile range) maxLCBI4mm was 448.4 (274.8 to 654.4) pre-PCI and decreased to 156.0 (75.6 to 312.6) post-PCI (p < 0.0001). Periprocedural MI developed in 21 patients (24.7%). The maxLCBI4mm was higher in patients with versus without MI (481.5 [425.6 to 679.6] vs. 371.5 [228.9 to 611.6], p = 0.05). Among 31 randomized lesions with maxLCBI4mm ≥600, there was no difference in the rates of periprocedural MI with versus without the use of a distal protection filter (35.7% vs. 23.5%, respectively; relative risk: 1.52; 95% confidence interval: 0.50 to 4.60, p = 0.69). Conclusions Plaque characterization by near-infrared spectroscopy identifies lipid-rich lesions with an increased likelihood of periprocedural MI after stent implantation, presumably due to distal embolization. However, in this pilot randomized trial, the use of a distal protection filter did not prevent myonecrosis after PCI of lipid-rich plaques.

KW - atherosclerosis

KW - distal protection

KW - embolization

KW - myocardial infarction

KW - near-infrared spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=84931443795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931443795&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2015.01.032

DO - 10.1016/j.jcin.2015.01.032

M3 - Article

C2 - 26003018

AN - SCOPUS:84931443795

SN - 1936-8798

VL - 8

SP - 927

EP - 936

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 7

M1 - 1997

ER -

Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this